Chieh Jason Chou

Dr. Chieh Jason Chou

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2016 in Scientific Reports
Verified
Journal Article
Open access
SRSylvie Rabot
Sylvie Rabot
MMMathieu Membrez
Mathieu Membrez
FBFlorence Blancher
Florence Blancher
BBBernard Berger
Bernard Berger
DMDéborah Moine
Déborah Moine
CCChieh Jason Chou
Chieh Jason Chou
The gut microbiota is involved in many aspects of host physiology but its role in body weight and glucose metabolism remains unclear. Here we studied the compositional changes of gut microbiota in diet-induced obesity mice that were conventionally raised or received microbiota transplantation. In conventional mice, the diversity of the faecal microbiota was weakly associated with 1st week weight gain but transferring the microbiota of mice with contrasting weight gain to germfree mice did not change obesity development or feed efficiency of recipients regardless whether the microbiota was taken before or after 10 weeks high fat (HF) feeding. Interestingly, HF-induced glucose intolerance was influenced by microbiota inoculation and improved glucose tolerance was associated with a low Firmicutes to Bacteroidetes ratio. Transplantation of Bacteroidetes rich microbiota compared to a control microbiota ameliorated glucose intolerance caused by HF feeding. Altogether, our results demonstrate that gut microbiota is involved in the regulation of glucose metabolism and the abundance of Bacteroidetes significantly modulates HF-induced glucose intolerance but has limited impact on obesity in mice. Our results suggest that gut microbiota is a part of complex aetiology of insulin resistance syndrome, individual microbiota composition may cause phenotypic variation associated with HF feeding in mice.

1 February 2014 in Applied Physiology, Nutrition, and Metabolism
Verified
Journal Article
Open access
TSTrent Stellingwerff
Trent Stellingwerff
JGJean-Philippe Godin
Jean-Philippe Godin
CCChieh Jason Chou
Chieh Jason Chou
DGDominik Grathwohl
Dominik Grathwohl
ARAlastair Ross
Alastair Ross
LALucas Actis-Goretta
Lucas Actis-Goretta
Consumption of cocoa-enriched dark chocolate (DC) has been shown to alter glucose and insulin concentration during rest and exercise compared with cocoa-depleted control (CON). However, the impact of DC consumption on exercise metabolism and performance is uncertain. Therefore, we investigated carbohydrate metabolism via stable isotope tracer techniques during exercise after subjects ingested either DC or CON. Sixteen overnight-fasted male cyclists performed a single-blinded, randomized, crossover design trial, after consuming either DC or CON at 2 h prior to 2.5 h of steady-state (SS) exercise (∼45% peak oxygen uptake). This was followed by an ∼15-min time-trial (TT) and 60 min of recovery. [6,6-2H2]Glucose and [U-13C]glucose were infused during SS to assess glucose rate of appearance (Ra) and disappearance (Rd). After DC consumption, plasma (−)-glucose and insulin concentrations were significantly (p < 0.001) elevated throughout vs. CON. During SS, there was no difference in [6,6-2H2]glucose Ra between treatments, but towards the end of SS (last 60 min) there was a ∼16% decrease in Rd in DC vs. CON (p < 0.05). Accordingly, after DC there was an ∼18% significant decrease in plasma glucose oxidation (trial effect; p = 0.032), and an ∼15% increase in tracer-derived muscle glycogen utilization (p = 0.045) late during SS exercise. The higher blood glucose concentrations during exercise and recovery after DC consumption coincided with high concentrations of epicatechin and (or) theobromine. In summary, DC consumption altered muscle carbohydrate partitioning, between muscle glucose uptake and glycogen oxidation, but did not effect cycling TT performance.

1 May 2001 in Obesity Research
Verified
Journal Article
Closed access
PDF file
CCChieh Jason Chou
Chieh Jason Chou
MCMing C. Cha
Ming C. Cha
DJDennis Jung
Dennis Jung
CBCarol N. Boozer
Carol N. Boozer
SHSami A. Hashim
Sami A. Hashim
FPF. Xavier Pi‐Sunyer
F. Xavier Pi‐Sunyer

6 November 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FRFrédéric Raymond
Frédéric Raymond
LWLong Wang
Long Wang
MMMireille Moser
Mireille Moser
SMSylviane Metairon
Sylviane Metairon
RMRobert Mansourian
Robert Mansourian
CCChieh Jason Chou
Chieh Jason Chou
Consumption of low-carbohydrate, high-protein, high-fat diets lead to rapid weight loss but the cardioprotective effects of these diets have been questioned. We examined the impact of high-protein and high-fat diets on cholesterol metabolism by comparing the plasma cholesterol and the expression of cholesterol biosynthesis genes in the liver of mice fed a high-fat (HF) diet that has a high (H) or a low (L) protein-to-carbohydrate (P/C) ratio. H-P/C-HF feeding, compared with L-P/C-HF feeding, decreased plasma total cholesterol and increased HDL cholesterol concentrations at 4-wk. Interestingly, the expression of genes involved in hepatic steroid biosynthesis responded to an increased dietary P/C ratio by first down-regulation (2-d) followed by later up-regulation at 4-wk, and the temporal gene expression patterns were connected to the putative activity of SREBF1 and 2. In contrast, Cyp7a1, the gene responsible for the conversion of cholesterol to bile acids, was consistently up-regulated in the H-P/C-HF liver regardless of feeding duration. Over expression of Cyp7a1 after 2-d and 4-wk H-P/C-HF feeding was connected to two unique sets of transcription regulators. At both time points, up-regulation of the Cyp7a1 gene could be explained by enhanced activations and reduced suppressions of multiple transcription regulators. In conclusion, we demonstrated that the hypocholesterolemic effect of H-P/C-HF feeding coincided with orchestrated changes of gene expressions in lipid metabolic pathways in the liver of mice. Based on these results, we hypothesize that the cholesterol lowering effect of high-protein feeding is associated with enhanced bile acid production but clinical validation is warranted. (246 words)

4 December 2018 in Analytical Chemistry
Verified
Journal Article
Closed access
ABArkadiy A. Bazhin
Arkadiy A. Bazhin
MCMarc Chambon
Marc Chambon
JVJonathan Vesin
Jonathan Vesin
JBJulien Bortoli
Julien Bortoli
JCJames W. Collins
James W. Collins
EGElena Goun
Elena Goun

7 March 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
SDShaillay Kumar Dogra
Shaillay Kumar Dogra
ADAdrien DARDINIER
Adrien DARDINIER
FMFabio Mainardi
Fabio Mainardi
LSLéa Siegwald
Léa Siegwald
SBSimona Bartova
Simona Bartova
CCChieh Jason Chou
Chieh Jason Chou
Faecalibacterium prausnitzii (F. prausnitzii) is a bacterial taxon in the human gut with anti-inflammatory properties, and this may contribute to the beneficial effects of healthy eating habits. However, little is known about the nutrients that enhance the growth of F. prausnitzii other than simple sugars and fibers. Here, we combined dietary and microbiome data from the American Gut Project (AGP) to identify nutrients that may be linked to the relative abundance of F. prausnitzii. Using a machine learning approach in combination with univariate analyses, we identified that sugar alcohols, carbocyclic sugar, and vitamins may contribute to F. prausnitzii growth. We next explored the effects of these nutrients on the growth of two F. prausnitzii strains in vitro and observed robust and strain-dependent growth patterns on sorbitol and inositol, respectively. In the context of a complex community using in vitro fermentation, neither inositol alone nor in combinations with vitamin B exerted a significant growth-promoting effect on F. prausnitzii, partly due to high variability among the fecal microbiota community from four healthy donors. However, the fecal communities that showed an increase in F. prausnitzii on inulin also responded with at least 60% more F. prausnitzii on any of inositol containing media than control. Future nutritional studies aiming to increase the relative abundance of F. prausnitzii should explore a personalized approach accounting for strain-level genetic variations and community-level microbiome composition.